Kevin Sayer, CEO, remains optimistic about the U.S. CGM market growth despite a temporary slowdown, expecting it to accelerate with improved execution. The 15-day G7 sensor filing and Stella product are anticipated to positively impact financials and contribute to market recovery in 2025.